As a result, they slow the rate of absorption of nutrients into the blood stream by reducing gastric emptying and may directly reduce food intake
Thyroid hormone controls carnitine status through modifications of gamma-butyrobetaine hydroxylase activity and gene expression
not an approved tanning agent
Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies
The current trial demonstrated the potentially useful role of GLP-1 receptor agonists to enhance weight-loss maintenance in the management of severe adolescent obesity, although we did not demonstrate a statistically significant result, the researchers wrote
Stephanie Weiss, M.D., Ph.D., assistant director for the Clinical Research, Medication Development Program at NIDA, shared data from the first published clinical trial of GLP-1 RAs in alcohol use disorder: in patients with obesity with a BMI over 30, exenatide reduced heavy drinking days by 23.6% and lowered total alcohol intake